EUVIMEDOdkrijte EUVIMED
Crossref

Microbial synthesis of gallic acid and its glucoside β‐glucogallin

Jiao Guo, Xiang Ren, Liangyu Lu, Ning An, Shuwei Li, Mingjie Geng, Geng Li, Xiaolin Shen, Xinxiao Sun, Jia Wang, Qipeng Yuan

Biotechnology and Bioengineering · 2024-11 · 121 (11) · 3527-3536

DOI: 10.1002/bit.28820 ↗

At a glance

Journal article in Biotechnology and Bioengineering, published online on 2024-07-30. Written by Jiao Guo and 10 co-authors. Institution: State Key Laboratory of Chemical Resource Engineering, Beijing University of Chemical Technology, Beijing, China. Major MEDLINE topics: Gallic Acid, Escherichia coli, Metabolic Engineering. Cited 22 times so far (Crossref); 35 references. Funded by: The National Key Research and Development Program of China, The National Natural Science Foundation of China.

PovzetekSubjectsBibliografski podatkiCiteRelated studies

Abstract (original language)

Gallic acid (GA) and β‐glucogallin (BGG) are natural products with diverse uses in pharmaceutical, food, chemical and cosmetic industries. They are valued for their wide‐ranging properties such as antioxidant, antibacterial, antidiabetic, and anticancer properties. Despite their significant importance, microbial production of GA and BGG faces challenges such as limited titers and yields, along with the incomplete understanding of BGG biosynthesis pathways in microorganisms. To address these challenges, we developed a recombinant Escherichia coli strain capable of efficiently producing GA. Our approach involved screening efficient pathway enzymes, integrating biosynthetic pathway genes into the genome while balancing carbon flux via adjusting expression levels, and strengthening the shikimate pathway to remove bottlenecks. The resultant strain achieved impressive results, producing 51.57 g/L of GA with a carbon yield of 0.45 g/g glucose and a productivity of 1.07 g/L/h. Furthermore, we extended this microbial platform to biosynthesize BGG by screening GA 1‐ O ‐glucosyltransferase, leading to the de novo production of 92.42 mg/L of BGG. This work establishes an efficient chassis for producing GA at an industrial level and provides a microbial platform for generating GA derivatives.

Subjects

MeSH terms (MEDLINE)

Gallic AcidEscherichia coliMetabolic EngineeringGlucosidesBiosynthetic PathwaysHydrolyzable Tannins

Author keywords

Escherichia coligallic acidmetabolic engineeringβ‐glucogallin

Substances

Gallic AcidglucogallinGlucosidesHydrolyzable Tannins

Authors and institutions

  • State Key Laboratory of Chemical Resource Engineering, Beijing University of Chemical Technology, Beijing, China.

Funding

  • The National Key Research and Development Program of China
  • The National Natural Science Foundation of China

Cite

APA

Guo, J., Ren, X., Lu, L., An, N., Li, S., Geng, M., Li, G., Shen, X., Sun, X., Wang, J., & Yuan, Q. (2024). Microbial synthesis of gallic acid and its glucoside β‐glucogallin. Biotechnology and Bioengineering, 121(11), 3527-3536. https://doi.org/10.1002/bit.28820

Vancouver

Guo J, Ren X, Lu L, An N, Li S, Geng M, et al. Microbial synthesis of gallic acid and its glucoside β‐glucogallin. Biotechnology and Bioengineering. 2024;121(11):3527-3536. doi:10.1002/bit.28820

BibTeX
@article{Guo2024,
  author = {Guo, Jiao and Ren, Xiang and Lu, Liangyu and An, Ning and Li, Shuwei and Geng, Mingjie and Li, Geng and Shen, Xiaolin and Sun, Xinxiao and Wang, Jia and Yuan, Qipeng},
  title = {Microbial synthesis of gallic acid and its glucoside β‐glucogallin},
  journal = {Biotechnology and Bioengineering},
  year = {2024},
  volume = {121},
  number = {11},
  pages = {3527--3536},
  doi = {10.1002/bit.28820}
}
Start for free →